InSpace Accelerated Rehabilitation Study

Last updated: July 30, 2024
Sponsor: Stryker Endoscopy
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

InSpace Subacromial Tissue Spacer

Clinical Study ID

NCT05329584
SYK-SM-2021-01
  • Ages > 65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This is a prospective, parallel group, open-label, multi- center, randomized study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Subjects MUST meet ALL the following criteria to be included in the study:

  • The subject has signed the IRB approved Informed Consent Form (ICF) specific to thisstudy prior to enrollment

  • Is male or female ≥ sixty-five (65) years of age

  • Positive diagnostic imaging by MRI within 9 months of enrollment of the indexshoulder indicating a full thickness MRCT:

  • Measuring ≥ 5 cm in diameter

  • Involving ≥ two tendons

  • Functional deltoid muscle and preserved passive range of motion on physicalexamination

  • Documented VAS score > 30 mm pain

  • Failed non-operative treatment of at least 3 months from the initial treatment toinclude one or more of the following:

  • Oral analgesics

  • Anti-inflammatory medication (e.g., ibuprofen, naproxen)

  • Corticosteroid injection(s)

  • Physical therapy

  • Activity modification

  • Rest (sling used)

  • Must be able to read and understand the approved Informed Consent Form (written andoral)

  • Must be in general good health (as determined by the Investigator) based onscreening assessments and medical history

  • Must be independent, ambulatory, and can comply with all post-operative evaluations,visits, and electronic database collection

Intra-operative Inclusion Criteria

Subjects MUST meet the following criteria to be randomized in the study:

  • Full thickness tear

  • Tear size ≥ 5 cm in diameter

  • Tear involving ≥ two tendons

Exclusion

Exclusion Criteria:

Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:

  • Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)

  • Evidence of the following conditions:

  • Severe gleno-humeral or acromio-humeral arthritis

  • Full thickness cartilage loss as seen on MRI

  • History within the past 5 years of anterior or posterior shoulder subluxationor dislocation as determined by history, examination, or radiographic findings

  • Pre-existing deltoid defect or deltoid palsy

  • Major joint trauma, infection, or necrosis

  • Partial thickness tears of the supraspinatus

  • Fully reparable rotator cuff tear [Tear of less than 5 cm in diameter (or < 4cm2) with retractable tendon that can be fully repaired]

  • Known neurovascular compromise

  • Complete deltoid muscle palsy

  • Traumatic muscle tears of the pectoralis or deltoid

  • The subject requires concomitant:

  • Subscapularis repair

  • Labral repair of any type

  • Biceps tenodesis

  • Previous surgery of the index shoulder in the past 1 year, excluding diagnosticarthroscopy

  • The subject's condition is bilateral and rotator cuff repair is scheduled or to bescheduled over the course of this study for the contra lateral shoulder

  • Major medical condition that could affect quality of life and influence the resultsof the study (e.g., rheumatoid arthritis)

  • The subject has documented evidence of a history (e.g., liver testing) ofdrug/alcohol abuse within 12 months of enrollment

  • The subject's condition represents a worker's compensation case

  • The subject is currently involved in a health-related litigation procedure

  • Females of child-bearing potential who are pregnant or plan to become pregnant.

  • Concurrent participation in an investigational clinical study one month prior toenrollment or during the entire study period

  • The subject is physically or mentally compromised (e.g., currently being treated fora psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extentthat the Investigator judges the subject to be unable or unlikely to remaincompliant to follow-up

  • The subject is receiving prescription narcotic pain medication for conditionsunrelated to the index shoulder condition

  • The subject currently has an acute infection in the area surrounding the surgicalsite.

  • Baseline WORC score less than 420

Intra-operative Exclusion Criteria:

Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:

  • Rotator cuff is/presents with:

  • Fully reparable with adequate tissue and muscle quality (equivalent toGoutallier stage 1 or 2)

  • Partial thickness tear of the supraspinatus

  • Evidence of significant osteoarthritis

  • The subject requires concomitant:

  • Subscapularis repair

  • Labral repair of any type

  • Biceps tenodesis

  • Coracoacromial ligament functional deficiency or shoulder instability is identified

Study Design

Total Participants: 160
Treatment Group(s): 1
Primary Treatment: InSpace Subacromial Tissue Spacer
Phase:
Study Start date:
February 07, 2022
Estimated Completion Date:
April 30, 2026

Study Description

Study Objectives:

Primary:

• To evaluate clinical outcomes of both a formalized or an at-home rehabilitation program when used in conjunction with the InSpace device as compared to the corresponding InSpace Pivotal study results.

  • To demonstrate consistency of each intervention group with the corresponding historical control study results.

  • To demonstrate that comparable clinical outcomes can be achieved for each intervention group.

Secondary:

• Change in clinical outcomes compared to baseline.

Connect with a study center

  • Musculoskeletal-Orthopedic Research and Education Foundation

    Phoenix, Arizona 85023
    United States

    Active - Recruiting

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas 72205
    United States

    Active - Recruiting

  • Steadman Hawkins Clinic Denver

    Englewood, Colorado 80112
    United States

    Active - Recruiting

  • UC Denver

    Englewood, Colorado 80112
    United States

    Active - Recruiting

  • Holy Cross Hospital

    Fort Lauderdale, Florida 33308
    United States

    Active - Recruiting

  • Paley Orthopaedics & Spine

    West Palm Beach, Florida 33407
    United States

    Active - Recruiting

  • Emory University

    Atlanta, Georgia 30329
    United States

    Active - Recruiting

  • Rush University Medical Center

    Chicago, Illinois 60612
    United States

    Active - Recruiting

  • Mayo Clinic

    Rochester, Minnesota 55905
    United States

    Active - Recruiting

  • Hospital for Special Surgery

    New York, New York 10021
    United States

    Active - Recruiting

  • The Rothman Institute

    Philadelphia, Pennsylvania 19107
    United States

    Active - Recruiting

  • TSAOG Orthopaedics & Spine

    San Antonio, Texas 78258
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.